{
  "company": {
    "name": "Duality Biologics",
    "website": "https://dualitybiologics.com/",
    "record": "https://startuphistory.org/c/dualitybiologics.com"
  },
  "status": null,
  "history_since": "2022-08-17T17:32:31.000Z",
  "baseline": {
    "snapshot_id": "a42866898971863b812f28a0926651b77bea9b922f691876bb2ad35753ccca5d",
    "observed_at": "2022-08-17T17:32:31.000Z",
    "headline": null,
    "description": "Duality Bio is a biotech company based in China. Our mission is to become the development and commercialization engine house for next generation biologics, and to provide innovative solutions to globa",
    "evidence": "https://web.archive.org/web/20220817173231/https://www.dualitybiologics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 0,
  "last_checked": null,
  "live_status": "offline",
  "messaging": [
    {
      "quote_observed_at": "2026-09-04T06:34:49.000Z",
      "variants": [
        {
          "headline": "抗体偶联药物ADC领域的全球领跑者-映恩生物",
          "subhead": "映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。公司已成功构建了多个具有全球知识产权的新一代ADC技术平台。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过17个国家开展多个全球多中心临床试验，入组超过2000名患者。",
          "observed_at": "2025-03-31T05:14:57.000Z",
          "evidence": "https://web.archive.org/web/20250331051457/https://www.dualitybiologics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "抗体偶联药物ADC领域的全球领跑者-映恩生物",
          "subhead": "映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。公司已成功构建了多个具有全球知识产权的新一代ADC技术平台。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过17个国家开展多个全球多中心临床试验，入组超过2000名患者。",
          "observed_at": "2025-09-02T22:21:43.000Z",
          "evidence": "https://web.archive.org/web/20250902222143/https://www.dualitybiologics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "抗体偶联药物ADC领域的全球领跑者-映恩生物",
          "subhead": "映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。公司已成功构建了多个具有全球知识产权的新一代ADC技术平台。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过17个国家开展多个全球多中心临床试验，入组超过2000名患者。",
          "observed_at": "2025-09-07T09:56:23.000Z",
          "evidence": "https://web.archive.org/web/20250907095623/https://www.dualitybiologics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "抗体偶联药物ADC领域的全球领跑者-映恩生物",
          "subhead": "映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。公司已成功构建了多个具有全球知识产权的新一代ADC技术平台。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过17个国家开展多个全球多中心临床试验，入组超过2000名患者。",
          "observed_at": "2026-03-17T15:47:56.000Z",
          "evidence": "https://web.archive.org/web/20260317154756/http://www.dualitybiologics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "抗体偶联药物ADC领域的全球领跑者-映恩生物",
          "subhead": "映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。公司已成功构建了多个具有全球知识产权的新一代ADC技术平台。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过17个国家开展多个全球多中心临床试验，入组超过2000名患者。",
          "observed_at": "2026-09-04T06:34:49.000Z",
          "evidence": "https://web.archive.org/web/20260904063449/https://www.dualitybiologics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "抗体偶联药物ADC领域的全球领跑者-映恩生物",
      "subhead": "映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。公司已成功构建了多个具有全球知识产权的新一代ADC技术平台。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过17个国家开展多个全球多中心临床试验，入组超过2000名患者。",
      "from": "2025-03-31T05:14:57.000Z",
      "to": "2026-09-04T06:34:49.000Z",
      "captures": 5,
      "evidence": "https://web.archive.org/web/20260904063449/https://www.dualitybiologics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2025-03-31T05:14:57.000Z",
          "to": "2026-09-04T06:34:49.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Duality Biologics” company record, https://startuphistory.org/c/dualitybiologics.com"
}